0.50
0.0179 (3.71%)
0.0179 (3.71%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 203,126 |
|
|||||
News | - | ||||||
Day High | 0.5045 | Low High |
|||||
Day Low | 0.477 |
Stock Name | Stock Symbol | Market | Stock Type |
---|---|---|---|
Aeglea BioTherapeutics Inc | AGLE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.4821 | 0.477 | 0.5045 | 0.50 | 0.4821 |
Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
480 | 203,126 | US$ 0.4905142 | US$ 99,636 | - | 0.34 - 4.54 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
11:44:36 | 8 | US$ 0.48 | USD |
Aeglea BioTherapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 30.76M | 61.51M | 56.95M | US$ 18.74M | US$ - | -1.00 | -0.40 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | US$ - | - | 1.88M | 2.40% |
Aeglea BioTherapeutics News
Date | Time | Source | News Article |
---|---|---|---|
18/1/2023 | 23:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
11/1/2023 | 08:37 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
09/1/2023 | 23:32 | Edgar (US Regulatory) | Current Report Filing (8-k) |
06/1/2023 | 23:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
06/1/2023 | 23:01 | PR Newswire (US) | Aeglea BioTherapeutics Announces Update to Corporate.. |
20/12/2022 | 08:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
03/12/2022 | 08:05 | PR Newswire (US) | Aeglea BioTherapeutics Reports Inducement Grant Under Nasdaq.. |
01/12/2022 | 04:25 | TipRanks | H.C. Wainwright Remains a Hold on Aeglea Biotherapeutics.. |
01/12/2022 | 02:05 | TipRanks | JonesTrading Reaffirms Their Buy Rating on Aeglea.. |
30/11/2022 | 23:01 | PR Newswire (US) | Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief.. |
16/11/2022 | 08:25 | PR Newswire (US) | Aeglea BioTherapeutics Appoints Linda Neuman, M.D., M.B.A,.. |
15/11/2022 | 22:39 | Edgar (US Regulatory) | Current Report Filing (8-k) |
Historical AGLE Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.51 | 0.52 | 0.4701 | 0.497497 | 174,876 | -0.01 | -1.96% |
1 Month | 0.435 | 0.6201 | 0.40 | 0.5114292 | 410,008 | 0.065 | 14.94% |
3 Months | 1.25 | 1.56 | 0.34 | 0.5566189 | 1,029,264 | -0.75 | -60.0% |
6 Months | 0.41 | 1.56 | 0.34 | 0.7815272 | 1,995,671 | 0.09 | 21.95% |
1 Year | 4.05 | 4.54 | 0.34 | 0.9534498 | 1,304,640 | -3.55 | -87.65% |
3 Years | 7.00 | 11.38 | 0.34 | 2.49 | 576,135 | -6.50 | -92.86% |
5 Years | 7.00 | 12.00 | 0.34 | 3.37 | 404,253 | -6.50 | -92.86% |